Rebecca Dielschneider

   -->
   PRINT TEXT SIZE   S  M  L  

Assistant Professor of Biology

Education

BSc., Department of Microbiology and Immunology, First Class Honours, with Co-op - Dalhousie University, 2011
Ph.D., Department of Immunology, University of Manitoba 2016

   

 

 

Professional

 

Teaching Fields

  • Biology
  • Anatomy
  • Physiology
  • Biochemistry
  • Genetics
  • Immunology
  • Microbiology
  • Cancer Biology

 

Professional Experience

2010 - Research Assistant, ImmunoVaccine Technologies Inc.

2010 - Research Assistant, Public Health Agency of Canada

2009 - Research Assistant, Public Health Agency of Canada

 

Select Awards

Simon and Sarah Israel's Thesis Prize, 2016

1st Place - CancerCare Manitoba Research Day (2013, 2014, 2016)

George D. Smith Award for Research Excellence - Canadian CLL Meeting (2015)

Gold Leaf Award for Emerging Leader Award in Biotechnology Research - BIOTECanada (2015)

Emerging Leader Award - University of Manitoba (2015)

Manitoba's Future 40 Under 40 - CBC (2015)

2nd Place - Canadian National Three Minute Thesis Competition (2015)

1st Place - University of Manitoba Three Minute Thesis Competition (2015)

Gold - National Competition, Canadian Student Health Research Forum (2014)

PhD Award (2 years of funding support, renewed) - Research Manitoba (2013, 2015)

Academic Excellence - Department of Immunology, University of Manitoba (2013)

Masters Award (1 year of funding support) - Canadian Institutes of Health Research (2012)

   
 

Professional Associations

Canadian Scientific and Christian Affiliation (CSCA)

Canadian Society of Molecular Biosciences (CMSB)

Canadian Society of Immunology (CSI)

American Association of Cancer Research (AACR)

   
 

Publications

 

Dissertations

Ph.D. Thesis "Targeting Susceptible Signaling Pathways in Chronic Lymphocytic Leukemia", 2016

B.Sc. Honours Thesis "Oncolysis and Immunomodulation in Ovarian Peritoneal Carcinomatosis", 2011

 

Peer-Reviewed Publications

Dielschneider R, Eisenstat H, Xiao WY, et al. Lysosomotropic Agents Selectively Target Chronic Lymphocytic Leukemia Cells Due to Altered Sphingolipid Metabolism. Leukemia, 2015; doi: 10.1038/leu.2016.4. 

Dielschneider R, Xiao WY, Yoon JY, et al. Gefitinib targets ZAP-70 expressing chronic lymphocytic leukemia cells and inhibits B cell receptor signaling. Cell Death and Disease, 2014; 5:e1439. doi: 10.1038/cddis.2014.391.

Gujar SA, Clements D, Dielschneider R, et al. Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumor immunological mechanisms. British Journal of Cancer, 2014; 110(1):83-93. doi: 10.1038/bjc.2013.695.

Gujar S, Dielschneider R, Clements D, et al. Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation. Molecular Therapy, 2013:21(2);338-47. doi: 10.1038/mt.2012.228.

 

 

Personal Interests

  Dogs, Hiking, Swimming, Beachcombing, Curling, Arts and Crafts
 

 Provf Talks

   
 

Course Information

 

Course Syllabi

232.23 Human Anatomy, Histology, and Physiology

235.11 Essentials of Microbiology

235.12 Introduction to Biology I (and Lab)

236.12 Introduction to Chemistry I and Wet Lab

239.11 Popular Life Science (formerly 235.12)

 

 
10 College Crescent
Otterburne, Manitoba, Canada, R0A 1G0
Phone: (204) 433-7488 or (800) 668-7768
Fax: (204) 433-7158
Copyright @ 2015 Providence
Privacy Policy